Events

ELSC-ICNC Seminar: Bernard Lerer

May 26, 2011

Bernard Lerer
Hadassah Medical School

On the topic:

Identification of Schizophrenia Susceptibility Genes in an Ethnically Homogeneous, Family-Based, Arab Israeli Sample

 

ICNC lecture hall (Silverman Bldg., Wing 3, 6th floor - Edmond J. Safra Campus)
May 26, 2011, at 17:00 

Abstrarct:

There is strong evidence supporting a heritable basis for schizophrenia, a severe neuropsychiatric disorder that has its onset in adolescence and early adulthood and has a lifetime prevalence of ~1%. Concerted efforts are being mounted to identify the specific genes that confer susceptibility to schizophrenia. These efforts have had limited success. We have taken the approach that the likelihood of finding schizophrenia susceptibility genes should be increased in ethnically homogeneous samples. In a genome-wide linkage study of schizophrenia in Arab Israeli families with multiple affected individuals, we previously reported significant evidence for a susceptibility locus at chromosome 6q23.2-q24.1 and suggestive evidence at chromosomes 10q22.3-26.3, 2q36.1-37.3 and 7p21.1-22.3 (1). To focus on the linkage peak and to identify susceptibility genes within the 6q23 region, fine-mapping was performed in the linkage sample (2) and extensive SNP genotyping was done in an expanded sample of Arab-Israeli nuclear families from the same geographical region of Israel (3, 4). The most significant genetic association with schizophrenia was detected within a genomic region that contains the AHI1 gene and the nearby C6orf217 gene (3, 4). The top SNP associations were further replicated in an independent case-control sample of Icelandic ancestry (5) and recently in large European and Spanish/German case-control samples (6, 7) and also in patients with autism. Translational studies from our laboratory provided convergent support for association of AHI1 with schizophrenia by demonstrating increased AHI1 expression in lymphoblast cell lines from schizophrenia patients in the Arab Israeli family sample and association of increased AHI1 expression with homozygosity for the over-expressed A allele of SNP rs932150, in brain samples from the Stanley Collection (8). Notwithstanding our replicated identification of schizophrenia susceptibility genes in the 6q region, additional associated variants could have been missed in our genome wide linkage study. With finer microsatellite mapping of the 10q23-q26 region we demonstrated stronger evidence for linkage with schizophrenia and identified a possible genetic interaction with the 6q23 region (9). To identify additional schizophrenia susceptibility genes, we applied a family-based GWAS strategy in an enlarged Arab Israeli family sample and found genome-wide significant association (best p-value=1.22x10-11) for 8 SNPs within or near highly reasonable functional candidate genes for schizophrenia. Of particular interest are a group of SNPs within and flanking the transcriptional repressor LRRFIP1 gene. To determine replicability of the significant associations beyond the Arab-Israeli population, we genotyped the SNPs in Jewish Israeli and German case-control samples and found replication of associations near the ACSL3, UGT1 subfamily and EFHD1 genes. Overall, this GWAS, which emphasizes the important contribution of family based studies, identifies promising candidate genes for schizophrenia.

 

References

 

1.    

 Lerer, B., Segman, R.H., Hamdan, A.,  Kanyas, K., Karni, O., Kohn, Y., Korner, M., Lanktree, M., Kaadan, M., Turetsky, N., Yakir, A., Kerem, B., Macciardi, F.: Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24. Molecular Psychiatry 8: 488–498, 2003.

2.    

 Levi, A., Kohn, Y., Kanyas, K., Amann, D., Pae, C.U., Hamdan, A., Segman, R.H., Avidan, N., Karni, O., Korner, M. et al. (2005) Fine mapping of a schizophrenia susceptibility locus at chromosome 6q23: increased evidence for linkage and reduced linkage interval. Eur. J. Hum. Genet., 13, 763-771.

3.    

Amann-Zalcenstein, D., Avidan, N., Kanyas, K., Ebstein, R.P., Kohn, Y., Hamdan, A., Ben-Asher, E., Karni, O., Mujaheed, M., Segman, R.H. et al. (2006) AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia. Eur. J. Hum. Genet., 14, 1111-1119.

4.    

Torri, F., Akelai, A., Lupoli, S., Sironi, M., Amann-Zalcenstein, D., Fumagalli, M., Dal Fiume, C., Ben-Asher, E., Kanyas, K., Cagliani, R. et al. (2010) Fine mapping of AHI1 as a schizophrenia susceptibility gene: from association to evolutionary evidence. FASEB J., 24, 3066-3082.

5.    

Ingason, A., Sigmundsson, T., Steinberg, S., Sigurdsson, E., Haraldsson, M., Magnusdottir, B.B., Frigge, M.L., Kong, A., Gulcher, J., Thorsteinsdottir, U. et al. (2007) Support for involvement of the AHI1 locus in schizophrenia. Eur. J. Hum. Genet., 15, 988-991.

6.    

Ingason, A., Giegling, I., Cichon, S., Hansen, T., Rasmussen, H.B., Nielsen, J., Jurgens, G., Muglia, P., Hartmann, A.M., Strengman, E. et al. (2010) A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. Hum. Mol. Genet., 19, 1379-1386.

7.    

Slonimsky, A., Levy, I., Kohn, Y., Rigbi, A., Ben-Asher, E., Lancet, D., Agam, G., Lerer, B. (2010) Lymphoblast and brain expression of AHI1 and the novel primate specific gene, C6orf217, in schizophrenia and bipolar disorder. Schizophrenia Research 120:159-166.

8.    

Rivero, O., Reif, A., Sanjuan, J., Molto, M.D., Kittel-Schneider, S., Najera, C., Topner, T. and Lesch, K.P. Impact of the AHI1 gene on the vulnerability to schizophrenia: a case-control association study. PLoS One, 5, e12254

9.     Alkelai, A., Kohn, Y., Olender, T., Sarner-Kanyas, K., Rigbi, A., Hamdan, A., Ben-Asher, E., Lancet, D. and Lerer, B. (2009) Evidence for an interaction of schizophrenia susceptibility loci on chromosome 6q23.3 and 10q24.33-q26.13 in Arab Israeli families. Am. J. Med. Genet. B Neuropsychiatr. Genet., 150B, 914-925.

ATTACHMENTS